Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient

Acute myeloid leukemia (AML) with inversion of chromosome 3 is characterized by overexpression of EVI1 and carries a dismal prognosis. Arsenic-containing compounds have been described to be efficacious in malignancies overexpressing EVI1. Here, we describe a case of AML with inv(3)(q21q26.2) treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Torsten H., Johnson, Nathalie, Garnier, Nicolas, Kwan, Stanley, Yao, Lu, Cocolakis, Eftihia, Hébert, Josée, Morgan, Robert A., Paquet, Éric, Callahan, Kevin P., Jordan, Craig T., Assouline, Sarit, Miller, Wilson H., Mann, Koren K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570070/
https://www.ncbi.nlm.nih.gov/pubmed/23408639
http://dx.doi.org/10.3389/fphar.2013.00009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570070/
https://www.ncbi.nlm.nih.gov/pubmed/23408639
http://dx.doi.org/10.3389/fphar.2013.00009

Ejemplares similares